Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women

PHASE2CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

February 29, 2008

Conditions
Hot Flashes
Interventions
DRUG

Gabapentin Extended Release tablets

1800mg

DRUG

Gabapentin

1800mg

Trial Locations (8)

Unknown

Burbank

DeLand

Port Orange

Shawnee

Baltimore

Hackensack

Greenville

San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Depomed

INDUSTRY

NCT00511953 - Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women | Biotech Hunter | Biotech Hunter